|
|
Article: New Research Could Lead to Potential Treatment for Avian Flu; Head Researcher Available for Comment on Hong Kong Influenza Research, SARS, Avian Flu and How They Are Connected.
- Article from:
- PR Newswire
- Article date:
- February 4, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SCOTTSDALE, Ariz., Feb. 4 /PRNewswire/ -- With the re-emergence of SARS and another outbreak of Avian Flu in Asia, many government officials are concerned the outbreaks will increase and a new epidemic will emerge. In response to this threat, ImmuneRegen BioSciences, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (BULLETIN BOARD: IRBH) , recently completed testing on the Hong Kong influenza virus, which is similar to that of SARS and the Avian Flu. Company executives believe this research may indicate efficacy of their proprietary compound, Homspera, in treating the Hong Kong respiratory virus in mice. Additionally, Company executives believe these test ...
Related newspaper, magazine, and journal articles:
|
|
Transcript: GROWING PANIC OVER HONG KONG AVIAN ...
World News Tonight with Peter Jennings;
December 26, 1997 ;
700+ words
...00-00-0000 FORREST SAWYER: In Hong Kong today, a growing panic over bird flu ... if the virus spreads anywhere beyond Hong Kong. Dr. ALAN HAY, National Institute ... the virus will be quickly contained in Hong Kong and that a vaccine will not be needed ...
|
|